BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

384 related articles for article (PubMed ID: 14555616)

  • 21. Insulin-like growth factor binding protein-3 induces early apoptosis in malignant prostate cancer cells and inhibits tumor formation in vivo.
    Devi GR; Sprenger CC; Plymate SR; Rosenfeld RG
    Prostate; 2002 May; 51(2):141-52. PubMed ID: 11948969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of IGFBP-6 as a significantly downregulated gene by beta-catenin in desmoid tumors.
    Denys H; Jadidizadeh A; Amini Nik S; Van Dam K; Aerts S; Alman BA; Cassiman JJ; Tejpar S
    Oncogene; 2004 Jan; 23(3):654-64. PubMed ID: 14737101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Inhibitory effect of bladder cancer related protein gene on HeLa cell proliferation].
    Zuo ZH; Zhao M; Liu J; Wei Y; Wu XX
    Ai Zheng; 2006 Jul; 25(7):811-7. PubMed ID: 16831269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of two-dimensional gel electrophoresis in studies on the role of cytoskeletal plaque proteins as tumor suppressors.
    Ben-Ze'ev A
    Electrophoresis; 1996 Nov; 17(11):1752-63. PubMed ID: 8982608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of S100P protein correlates with and contributes to the tumorigenic capacity of HeLa cervical carcinoma cells.
    Gibadulinová A; Baráthová M; Kopácek J; Hulíková A; Pastoreková S; Kettmann R; Pastorek J
    Oncol Rep; 2005 Aug; 14(2):575-82. PubMed ID: 16012747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. IGFBP-3 expression in hepatocellular carcinoma involves abnormalities in TGF-beta and/or Rb signaling pathways.
    Yumoto E; Nakatsukasa H; Hanafusa T; Yumoto Y; Nouso K; Matsumoto E; Onishi T; Takuma Y; Tanaka H; Fujikawa T; Suzuki M; Uemura M; Shiratori Y
    Int J Oncol; 2005 Nov; 27(5):1223-30. PubMed ID: 16211216
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DICKKOPF-4 is induced by TCF/beta-catenin and upregulated in human colon cancer, promotes tumour cell invasion and angiogenesis and is repressed by 1alpha,25-dihydroxyvitamin D3.
    Pendás-Franco N; García JM; Peña C; Valle N; Pálmer HG; Heinäniemi M; Carlberg C; Jiménez B; Bonilla F; Muñoz A; González-Sancho JM
    Oncogene; 2008 Jul; 27(32):4467-77. PubMed ID: 18408752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of the Wilms' tumor suppressor gene, WT1, reduces the tumorigenicity of the leukemic cell line M1 in C.B-17 scid/scid mice.
    Smith SI; Down M; Boyd AW; Li CL
    Cancer Res; 2000 Feb; 60(4):808-14. PubMed ID: 10706085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Aberrant expression and function of TCF4 in the proliferation of hepatocellular carcinoma cell line BEL-7402.
    Zhao DH; Hong JJ; Guo SY; Yang RL; Yuan J; Wen CY; Zhou KY; Li CJ
    Cell Res; 2004 Feb; 14(1):74-80. PubMed ID: 15040893
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
    Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
    Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Suppression of growth and tumorigenicity in the prostate tumor cell line M12 by overexpression of the transcription factor SOX9.
    Drivdahl R; Haugk KH; Sprenger CC; Nelson PS; Tennant MK; Plymate SR
    Oncogene; 2004 Jun; 23(26):4584-93. PubMed ID: 15077158
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of tumorigenicity, but not anchorage independence, of human cancer cells by new candidate tumor suppressor gene CapG.
    Watari A; Takaki K; Higashiyama S; Li Y; Satomi Y; Takao T; Tanemura A; Yamaguchi Y; Katayama I; Shimakage M; Miyashiro I; Takami K; Kodama K; Yutsudo M
    Oncogene; 2006 Nov; 25(56):7373-80. PubMed ID: 16767159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Smad1, beta-catenin and Tcf4 associate in a molecular complex with the Myc promoter in dysplastic renal tissue and cooperate to control Myc transcription.
    Hu MC; Rosenblum ND
    Development; 2005 Jan; 132(1):215-25. PubMed ID: 15576399
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Smad4 induces the tumor suppressor E-cadherin and P-cadherin in colon carcinoma cells.
    Müller N; Reinacher-Schick A; Baldus S; van Hengel J; Berx G; Baar A; van Roy F; Schmiegel W; Schwarte-Waldhoff I
    Oncogene; 2002 Sep; 21(39):6049-58. PubMed ID: 12203117
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and validation of a gene involved in anchorage-independent cell growth control using a library of randomized hairpin ribozymes.
    Welch PJ; Marcusson EG; Li QX; Beger C; Krüger M; Zhou C; Leavitt M; Wong-Staal F; Barber JR
    Genomics; 2000 Jun; 66(3):274-83. PubMed ID: 10873382
    [TBL] [Abstract][Full Text] [Related]  

  • 37. IGFBP-3 is a direct target of transcriptional regulation by DeltaNp63alpha in squamous epithelium.
    Barbieri CE; Perez CA; Johnson KN; Ely KA; Billheimer D; Pietenpol JA
    Cancer Res; 2005 Mar; 65(6):2314-20. PubMed ID: 15781645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IRF-1 reverts the transformed phenotype of oncogenically transformed cells in vitro and in vivo.
    Kröger A; Dallügge A; Kirchhoff S; Hauser H
    Oncogene; 2003 Feb; 22(7):1045-56. PubMed ID: 12592391
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of insulin-like growth factor binding proteins in 1alpha,25-dihydroxyvitamin D(3)-induced growth inhibition of human prostate cancer cells.
    Stewart LV; Weigel NL
    Prostate; 2005 Jun; 64(1):9-19. PubMed ID: 15651061
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of the leukocyte cell-derived chemotaxin 2 as a direct target gene of beta-catenin in the liver.
    Ovejero C; Cavard C; Périanin A; Hakvoort T; Vermeulen J; Godard C; Fabre M; Chafey P; Suzuki K; Romagnolo B; Yamagoe S; Perret C
    Hepatology; 2004 Jul; 40(1):167-76. PubMed ID: 15239100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.